Can midodrine (alpha-adrenergic agonist) cause bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midodrine Can Cause Bradycardia

Yes, midodrine can cause bradycardia due to reflex parasympathetic stimulation. 1 This is an important side effect that clinicians should monitor for when prescribing this medication.

Mechanism of Bradycardia with Midodrine

Midodrine is a peripheral alpha-1 adrenergic agonist that works by causing vasoconstriction, which increases blood pressure. The bradycardia occurs through the following mechanism:

  • When midodrine increases blood pressure through vasoconstriction, it triggers the baroreceptor reflex
  • This reflex activates parasympathetic (vagal) stimulation to the heart
  • The resulting vagal reflex leads to a slowing of the heart rate 2

Risk Factors for Midodrine-Induced Bradycardia

Patients at higher risk for developing bradycardia with midodrine include those:

  • Taking other negative chronotropic agents such as:
    • Beta-blockers
    • Digoxin
    • Non-dihydropyridine calcium channel blockers 1
  • Using cardiac glycosides (such as digitalis) 2
  • Taking psychopharmacologic agents that can affect heart rate 2

Monitoring and Management

When prescribing midodrine, the following monitoring and management strategies should be implemented:

  • Monitor heart rate before and after initiating therapy
  • Advise patients to report any symptoms suggesting bradycardia:
    • Increased dizziness
    • Syncope
    • Cardiac awareness
    • Pulse slowing 2
  • If bradycardia occurs, discontinue midodrine and re-evaluate the patient 2
  • Consider alternative treatments for orthostatic hypotension in patients with pre-existing bradycardia or those on other medications that slow heart rate

Dosing Considerations

  • Standard dosing: 5-20 mg three times daily 3
  • For dialysis patients: 5 mg administered 30 minutes before dialysis session 1, 3
  • In patients with renal impairment: Start with a lower dose of 2.5 mg 3, 2
  • Schedule the last daily dose at least 4 hours before bedtime to minimize supine hypertension 2

Other Important Side Effects

While monitoring for bradycardia, clinicians should also be aware of other potential adverse effects:

  • Supine hypertension (most significant concern)
  • Piloerection (goosebumps)
  • Scalp itching or tingling
  • Urinary retention or urgency
  • Gastrointestinal symptoms (nausea, heartburn)
  • Headache and sleep disturbances 1

Clinical Pearls

  • Midodrine is effectively cleared by hemodialysis with a reduced half-life of 1.4 hours during dialysis 1
  • Avoid concomitant use with other alpha-adrenergic agents (ephedrine, pseudoephedrine, phenylpropanolamine) as this may worsen supine hypertension 1, 2
  • Midodrine can antagonize the actions of alpha-adrenergic blockers (terazosin, prazosin, doxazosin) and could result in urinary retention 1
  • In severe overdose cases, bradycardia can be profound, as reported in a case with heart rate ranging from 43-60 beats/min 4

Remember that while midodrine is an effective treatment for orthostatic hypotension, careful monitoring for bradycardia and other side effects is essential for safe use of this medication.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Orthostatic Hypotension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Severe Hypertension and Bradycardia Secondary to Midodrine Overdose.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.